Cellular site and mode of Fv-2 gene action. II. Conditional protection of Fv-2ss cells by admixture with Fv-2rr cells
- PMID: 2707315
Cellular site and mode of Fv-2 gene action. II. Conditional protection of Fv-2ss cells by admixture with Fv-2rr cells
Abstract
Fv-2ss marrow cells are protected in vivo from Friend virus-induced erythroleukemia by admixture with a preponderance of Fv-2rr marrow cells. This was demonstrated both in allophenic (mosaic) mice and in bone marrow chimeras constructed from C57BL/6 strains differing at Fv-2 and an enzyme marker (glucose phosphate isomerase). The bone marrow chimeras were constructed by injection of marrow cells from Fv-2ss mice into unirradiated Fv-2rr mice. Bone marrow chimeras derived from this procedure produced 1%-2% donor (Fv-2ss) erythrocytes; this level of chimerism was maintained indefinitely. All the bone marrow chimeras as well as allophenic mice with less than 20% Fv-2ss red cells failed to develop any of the symptoms of Friend disease after infection with the polycythemic strain of Friend virus. The Fv-2rr-mediated protection of Fv-2ss marrow cells could be reversed by pretreatment of the two types of chimeras with either monoclonal or polyclonal antithymocyte antisera. Chimeras treated with either reagent and infected with Friend virus developed symptoms of Friend disease and experienced a shift in their erythrocyte mosaic composition favoring cells of the susceptible genotype. These results are consistent with the notion that a functioning immune system plays a role in the Fv-2rr-mediated protection of Fv-2ss Friend virus target cells. Furthermore, these studies establish conditions whereby a small population of sensitive strain cells in an overwhelming background of resistant strain cells can be selectively expanded. Such conditions could be useful in efforts to clone the Fv-2 gene.
Similar articles
-
Friend viral pathogenesis in C57BL/6 reversible DBA/2 allophenic mice.Exp Hematol. 1982 Oct;10(9):723-31. Exp Hematol. 1982. PMID: 7173342
-
Genotype-limited changes in platelet and erythroid kinetics in Friend-virus-infected allophenic mice.Exp Hematol. 1986 Jun;14(5):380-5. Exp Hematol. 1986. PMID: 3709707
-
Genetic resistance to Friend leukemia virus in mice: masking of Fv-2 phenotype by an epistatic gene, Fv-4.Jpn J Exp Med. 1977 Dec;47(6):515-21. Jpn J Exp Med. 1977. PMID: 609115
-
Friend leukemia: a model for the physiopathology of human chronic leukemia.Eur J Cancer (1965). 1975 Dec;11(12):831-40. doi: 10.1016/0014-2964(75)90081-x. Eur J Cancer (1965). 1975. PMID: 767113 Review. No abstract available.
-
The molecular pathology of Friend erythroleukemia virus strains. An overview.Biochim Biophys Acta. 1985;780(3):181-95. doi: 10.1016/0304-419x(85)90002-2. Biochim Biophys Acta. 1985. PMID: 3896311 Review. No abstract available.
Cited by
-
CD4(+) T cells and gamma interferon in the long-term control of persistent friend retrovirus infection.J Virol. 2001 Jan;75(1):52-60. doi: 10.1128/JVI.75.1.52-60.2001. J Virol. 2001. PMID: 11119573 Free PMC article.
-
Role of erythropoietin receptor signaling in Friend virus-induced erythroblastosis and polycythemia.Blood. 2006 Jan 1;107(1):73-8. doi: 10.1182/blood-2005-05-1784. Epub 2005 Sep 20. Blood. 2006. PMID: 16174761 Free PMC article.
-
ART-CH: a VL30 in chickens?J Virol. 1994 Feb;68(2):846-53. doi: 10.1128/JVI.68.2.846-853.1994. J Virol. 1994. PMID: 7904657 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical